Stock OMIC SINGULAR GENOMICS SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Singular Genomics Systems, Inc.

Equities

OMIC

US82933R1005

Market Closed - Nasdaq
Other stock markets
 21:30:01 03/05/2024 BST 		5-day change 1st Jan Change
0.4131 USD +3.28% Intraday chart for Singular Genomics Systems, Inc. +2.20% -10.22%
03-20 UBS Adjusts Singular Genomics Systems Price Target to $0.50 From $0.40, Maintains Neutral Rating MT
03-18 Transcript : Singular Genomics Systems, Inc., Q4 2023 Earnings Call, Mar 18, 2024

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Singular Genomics Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Singular Genomics Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Singular Genomics Systems, Inc. Showcases New G4X? Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4 Sequencing Platform
Singular Genomics Unveils G4X Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis
Singular Genomics Systems, Inc. Provides Unaudited Revenue Guidance for the Fourth Quarter of 2023
Singular Genomics Systems Expects 31% Growth in Q4 Revenue
Singular Genomics Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Fluent BioSciences Inc. Announces A Partnership with Singular Genomics
Singular Genomics Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Singular Genomics Appoints Marcia Eisenberg, Ph.D., to Board of Directors
Singular Genomics Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Singular Genomics Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Singular Genomics Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
Singular Genomics Systems, Inc. Launches Max Read Kits for Single Cell Sequencing on the G4 At AGBT
Singular Genomics' G4 Sequencing Platform Joins 10x Genomics Compatible Partner Program
Singular Genomics Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Singular Genomics Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Singular Genomics Systems, Inc. Announces Management Appointments
Singular Genomics Systems Files $250 Million Mixed Shelf
Singular Genomics and Olink Holding AB Collaborate to Enable Olink Explore on the G4 Max Read Sequencing Kits
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OMIC Stock
  4. News Singular Genomics Systems, Inc.
  5. Other languages